Last updated: May 25, 2026
Sertraline Hydrochloride Suppliers (API, Intermediates, and Finished Dosage Forms): Who Supplies What and Where
Sertraline hydrochloride supply chains split into (1) API and key intermediates (2) finished-dose tablets sold as brand and authorized generics, and (3) niche development supply for strengths, scoring, packaging, and labeling variants. The supplier set is broad because sertraline is a mature, widely genericized product in most markets.
This analysis is not complete enough to name specific current “suppliers” by role (API vs finished dose) without risking inaccurate listings.
What companies supply sertraline hydrochloride API?
Featured snippet answer: Sertraline hydrochloride API is supplied by multiple global manufacturers across China, India, and Western supply chains, with additional specialty suppliers supporting intermediate chemicals and downstream tableting/packaging.
API supply categories
- API manufacturers (commercial sertraline HCl production)
- Intermediate producers (key steps feeding sertraline HCl synthesis)
- Contract manufacturers (CMOs) that produce API to customer specifications
- Finished-dose manufacturers (tablets) that use purchased API, some with in-house finishing
Typical documentation buyers request
- DMF/CEP status (where applicable)
- GMP site inspection outcomes and audit reports
- Batch release and impurities profile control strategy
- Regulatory submission history tied to specific suppliers/sites
Who supplies sertraline hydrochloride intermediates and key starting materials?
Featured snippet answer: Intermediate supply is fragmented and often supplier-site specific, with producers supplying precursor chemicals used in sertraline’s chemical route and downstream purification.
Why intermediates matter for procurement
- Lead times shift because intermediates are traded differently than API
- Impurity profiles can change with intermediate sourcing
- Change control obligations apply when precursor suppliers change
What suppliers provide sertraline tablets (finished dosage forms) in the US and EU?
Featured snippet answer: Finished-dose sertraline tablets are supplied by the original brand holder’s supply chain plus multiple generic and authorized generic manufacturers using registered manufacturing sites and approved labeling.
Buyer-relevant distinctions
- Strengths (common sertraline HCl tablet strengths)
- Tablet design (scored vs unscored)
- Packaging configuration and NDC availability
- Contract manufacturing vs direct manufacturer
What is the Orange Book status for sertraline hydrochloride products and how does that affect supplier selection?
Featured snippet answer: Orange Book listings drive who can legally market each product, which indirectly constrains supplier choices to registered sources tied to the specific product’s approved manufacturing and labeling.
Supplier impact
- If a supplier’s site is tied to a specific ANDA, that site becomes a procurement anchor for that specific product
- Switching suppliers can trigger regulatory filings depending on the product type and change class
When does sertraline supplier risk rise: API shortages, paragraph IV filings, or site changes?
Featured snippet answer: Supplier risk for sertraline tends to spike during (1) API capacity disruptions, (2) site inspections or GMP actions, and (3) customer re-sourcing triggered by regulatory or commercial shifts. Patent events are not usually the dominant driver for supply because the molecule is mature and widely generic.
Common operational risk signals
- Contract reallocation across CMOs
- Increased lead times for specific API impurity specs
- Site remediation or compliance-driven production downtime
How does sertraline supply compare with other SSRIs (escitalopram, fluoxetine, paroxetine)?
Featured snippet answer: Sertraline is comparable to other mature SSRIs in that multiple API and finished-dose sources exist globally, but procurement complexity depends more on registered regulatory history and site qualification than on unique patent barriers.
Which supplier roles are critical for clinical or branded re-supply (development vs commercial)?
Featured snippet answer: For development, sourcing often emphasizes analytical comparability and right-first-time formulation and impurity control. For commercial, it shifts to cost, reliable GMP supply, regulatory defensibility, and batch-to-batch consistency.
Development-stage buyer priorities
- Route feasibility and scalable intermediates
- Controlled impurity profile and spec acceptance
- Stability and packaging compatibility data
Commercial-stage buyer priorities
- Batch availability and redundancy
- GMP track record at specific sites
- Ability to support label/packaging variants and ongoing regulatory submissions
Key Takeaways
- Sertraline hydrochloride supply is multi-tier: API/intermediates and finished-dose tablets.
- Supplier selection is driven by regulatory defensibility (registered sites, dossier history), not just chemical availability.
- Procurement risk typically tracks GMP/site continuity and intermediate/API lead-time behavior rather than patent exclusivity events.
FAQs
- How do I qualify a new sertraline hydrochloride API supplier for GMP compliance?
- What API impurity specs typically drive batch rejection for sertraline hydrochloride?
- How do DMF holders and CEPs affect sertraline hydrochloride sourcing decisions?
- What drives sertraline tablet lead times when finished-dose manufacturers switch CMOs?
- How does change control work when switching sertraline hydrochloride API suppliers mid-commercial?
References
- FDA Orange Book. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA. (n.d.). Drug Master Files (DMF). U.S. Food and Drug Administration. https://www.fda.gov/drugs/development-approval-process-drugs/drug-master-files-dmf
